Yannick Le Bris

19PUBLICATIONS
105CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 19, 2026
CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Candice Madiot, Céline Bellanger, Christelle Dousset

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Sep 14, 2024
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.

Cédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert

|Jan 02, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois

|Dec 14, 2023
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.

Romane Durand, Géraldine Descamps, Céline Bellanger

|Aug 10, 2023
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.

Salomé Decombis, Celine Bellanger, Yannick Le Bris

Pageof 4

Frequent Collaborators

6 joint publications

Benoît Tessoulin

5 joint publications

Marie-Christine Béné

4 joint publications

Marion Eveillard

3 joint publications

David Chiron